LASERS IN MEDICAL SCIENCE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2164855, encodeId=a26b21648551f, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：激光;口腔 经验分享：2分三区的杂志，审稿时间快慢不等。我自己遇到的编辑太忙，整个审稿过程单editor assignment pending就等了好几个月。如果见刊着急，这个杂志不是首选。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/3139c474f6e446a89f99c689b5b972c3/ef7907b6b2da40c78b0f038f424e69cd.png, createdBy=d8b52097943, createdName=lifesaver_80639729, createdTime=Wed Oct 25 17:12:57 CST 2023, time=2023-10-25, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2123944, encodeId=a2a7212394426, content=偏重的研究方向：医学;手术 经验分享：Reviewers agreed是说明已经有审稿人接受了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a55f8299328, createdName=宝强, createdTime=Wed Apr 05 20:46:35 CST 2023, time=2023-04-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=955270, encodeId=68009552e042, content=投稿命中率:50.0 经验分享：2020年9月2号投稿 2020年12月10小修 2021年1月1号修回 2021年2月10号接收目前还没有proof 速度偏慢。有没有已经在线的分享一下进度啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Thu Apr 08 18:33:35 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101717, encodeId=d99d2101e17b5, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：激光;疤痕 经验分享：Initial Date Submitted 12 Sep 2022 Accept 20 Nov 2022 速度还好，一次大修，一次小修，分值不高但是中科院3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33f36539713, createdName=ms9000000605363612, createdTime=Mon Nov 21 09:31:29 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093336, encodeId=a6852093336e5, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：医学;激光 经验分享：耐得住，真的好慢好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=692b6388930, createdName=ms3000001418780631, createdTime=Wed Oct 12 10:02:42 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555829, encodeId=096f5558294f, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：Dec 22, 2017 Submitted Dec 26, 2017 返回（缺动物伦理） Dec 27, 2017 Submitted Dec 27, 2017 Editor Invited Dec 28, 2017 Under Review Mar 25, 2018 Status Date变化（状态仍然为Under review） Mar 31, 2018 Minor Revise Apr 08, 2018 Submitted Apr 18, 2018 Under Review May 2, 2018 Reviews Completed May 3, 2018 Editor Assignment Pending May 4, 2018 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/8ab47519872135abb0a73648d5c28db5/e26e9c24b8c138494e359b288b9601d9.jpg, createdBy=96e82024468, createdName=欢乐的树博士, createdTime=Tue May 08 09:37:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011142, encodeId=3680101114230, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：激光;Supramaximal-area scars;大面积瘢痕 经验分享：18 Jun 2021 submitted 17 July 2021 under review 02 Aug 2021 minor 04 Aug 2021 revised + Editor invited 16 Aug 2021 Editor Assignemnt Pending 18 Aug 2021 ACCEPT Study focus on fractional CO2 laser treating Supramaximal-area scars, a retrospective study. Two months accept, I believe is worst a try. ^^, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1545312076, createdName=1488cc95m79(暂无昵称), createdTime=Tue Aug 24 21:57:59 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094654, encodeId=d7b8109465443, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094653, encodeId=75ef10946536f, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902348, encodeId=a9c190234813, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿后一个月编辑送审，外审两个月后大修，修回后又外审一个月，返回小修，小修后又送外审一月后接受。编辑态度比较严谨，对稿件格式要求很高，联系投稿前多检查几次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=301d2439800, createdName=zphgccf, createdTime=Thu Nov 26 02:04:05 CST 2020, time=2020-11-26, status=1, ipAttribution=)]

2023-10-25 lifesaver_80639729 来自山西省

审稿速度:12.0 | 投稿命中率:75.0
偏重的研究方向：激光;口腔
经验分享：2分三区的杂志，审稿时间快慢不等。我自己遇到的编辑太忙，整个审稿过程单editor assignment pending就等了好几个月。如果见刊着急，这个杂志不是首选。

21 0

[GetPortalCommentsPageByObjectIdResponse(id=2164855, encodeId=a26b21648551f, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：激光;口腔 经验分享：2分三区的杂志，审稿时间快慢不等。我自己遇到的编辑太忙，整个审稿过程单editor assignment pending就等了好几个月。如果见刊着急，这个杂志不是首选。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/3139c474f6e446a89f99c689b5b972c3/ef7907b6b2da40c78b0f038f424e69cd.png, createdBy=d8b52097943, createdName=lifesaver_80639729, createdTime=Wed Oct 25 17:12:57 CST 2023, time=2023-10-25, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2123944, encodeId=a2a7212394426, content=偏重的研究方向：医学;手术 经验分享：Reviewers agreed是说明已经有审稿人接受了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a55f8299328, createdName=宝强, createdTime=Wed Apr 05 20:46:35 CST 2023, time=2023-04-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=955270, encodeId=68009552e042, content=投稿命中率:50.0 经验分享：2020年9月2号投稿 2020年12月10小修 2021年1月1号修回 2021年2月10号接收目前还没有proof 速度偏慢。有没有已经在线的分享一下进度啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Thu Apr 08 18:33:35 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101717, encodeId=d99d2101e17b5, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：激光;疤痕 经验分享：Initial Date Submitted 12 Sep 2022 Accept 20 Nov 2022 速度还好，一次大修，一次小修，分值不高但是中科院3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33f36539713, createdName=ms9000000605363612, createdTime=Mon Nov 21 09:31:29 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093336, encodeId=a6852093336e5, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：医学;激光 经验分享：耐得住，真的好慢好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=692b6388930, createdName=ms3000001418780631, createdTime=Wed Oct 12 10:02:42 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555829, encodeId=096f5558294f, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：Dec 22, 2017 Submitted Dec 26, 2017 返回（缺动物伦理） Dec 27, 2017 Submitted Dec 27, 2017 Editor Invited Dec 28, 2017 Under Review Mar 25, 2018 Status Date变化（状态仍然为Under review） Mar 31, 2018 Minor Revise Apr 08, 2018 Submitted Apr 18, 2018 Under Review May 2, 2018 Reviews Completed May 3, 2018 Editor Assignment Pending May 4, 2018 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/8ab47519872135abb0a73648d5c28db5/e26e9c24b8c138494e359b288b9601d9.jpg, createdBy=96e82024468, createdName=欢乐的树博士, createdTime=Tue May 08 09:37:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011142, encodeId=3680101114230, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：激光;Supramaximal-area scars;大面积瘢痕 经验分享：18 Jun 2021 submitted 17 July 2021 under review 02 Aug 2021 minor 04 Aug 2021 revised + Editor invited 16 Aug 2021 Editor Assignemnt Pending 18 Aug 2021 ACCEPT Study focus on fractional CO2 laser treating Supramaximal-area scars, a retrospective study. Two months accept, I believe is worst a try. ^^, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1545312076, createdName=1488cc95m79(暂无昵称), createdTime=Tue Aug 24 21:57:59 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094654, encodeId=d7b8109465443, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094653, encodeId=75ef10946536f, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902348, encodeId=a9c190234813, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿后一个月编辑送审，外审两个月后大修，修回后又外审一个月，返回小修，小修后又送外审一月后接受。编辑态度比较严谨，对稿件格式要求很高，联系投稿前多检查几次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=301d2439800, createdName=zphgccf, createdTime=Thu Nov 26 02:04:05 CST 2020, time=2020-11-26, status=1, ipAttribution=)]

2023-04-05 宝强来自四川省

偏重的研究方向：医学;手术
经验分享：Reviewers agreed是说明已经有审稿人接受了吗？

29 0

[GetPortalCommentsPageByObjectIdResponse(id=2164855, encodeId=a26b21648551f, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：激光;口腔 经验分享：2分三区的杂志，审稿时间快慢不等。我自己遇到的编辑太忙，整个审稿过程单editor assignment pending就等了好几个月。如果见刊着急，这个杂志不是首选。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/3139c474f6e446a89f99c689b5b972c3/ef7907b6b2da40c78b0f038f424e69cd.png, createdBy=d8b52097943, createdName=lifesaver_80639729, createdTime=Wed Oct 25 17:12:57 CST 2023, time=2023-10-25, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2123944, encodeId=a2a7212394426, content=偏重的研究方向：医学;手术 经验分享：Reviewers agreed是说明已经有审稿人接受了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a55f8299328, createdName=宝强, createdTime=Wed Apr 05 20:46:35 CST 2023, time=2023-04-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=955270, encodeId=68009552e042, content=投稿命中率:50.0 经验分享：2020年9月2号投稿 2020年12月10小修 2021年1月1号修回 2021年2月10号接收目前还没有proof 速度偏慢。有没有已经在线的分享一下进度啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Thu Apr 08 18:33:35 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101717, encodeId=d99d2101e17b5, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：激光;疤痕 经验分享：Initial Date Submitted 12 Sep 2022 Accept 20 Nov 2022 速度还好，一次大修，一次小修，分值不高但是中科院3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33f36539713, createdName=ms9000000605363612, createdTime=Mon Nov 21 09:31:29 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093336, encodeId=a6852093336e5, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：医学;激光 经验分享：耐得住，真的好慢好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=692b6388930, createdName=ms3000001418780631, createdTime=Wed Oct 12 10:02:42 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555829, encodeId=096f5558294f, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：Dec 22, 2017 Submitted Dec 26, 2017 返回（缺动物伦理） Dec 27, 2017 Submitted Dec 27, 2017 Editor Invited Dec 28, 2017 Under Review Mar 25, 2018 Status Date变化（状态仍然为Under review） Mar 31, 2018 Minor Revise Apr 08, 2018 Submitted Apr 18, 2018 Under Review May 2, 2018 Reviews Completed May 3, 2018 Editor Assignment Pending May 4, 2018 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/8ab47519872135abb0a73648d5c28db5/e26e9c24b8c138494e359b288b9601d9.jpg, createdBy=96e82024468, createdName=欢乐的树博士, createdTime=Tue May 08 09:37:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011142, encodeId=3680101114230, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：激光;Supramaximal-area scars;大面积瘢痕 经验分享：18 Jun 2021 submitted 17 July 2021 under review 02 Aug 2021 minor 04 Aug 2021 revised + Editor invited 16 Aug 2021 Editor Assignemnt Pending 18 Aug 2021 ACCEPT Study focus on fractional CO2 laser treating Supramaximal-area scars, a retrospective study. Two months accept, I believe is worst a try. ^^, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1545312076, createdName=1488cc95m79(暂无昵称), createdTime=Tue Aug 24 21:57:59 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094654, encodeId=d7b8109465443, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094653, encodeId=75ef10946536f, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902348, encodeId=a9c190234813, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿后一个月编辑送审，外审两个月后大修，修回后又外审一个月，返回小修，小修后又送外审一月后接受。编辑态度比较严谨，对稿件格式要求很高，联系投稿前多检查几次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=301d2439800, createdName=zphgccf, createdTime=Thu Nov 26 02:04:05 CST 2020, time=2020-11-26, status=1, ipAttribution=)]

2021-04-08 122220a4m01暂无昵称

投稿命中率:50.0
经验分享：2020年9月2号投稿 2020年12月10小修 2021年1月1号修回 2021年2月10号接收目前还没有proof 速度偏慢。有没有已经在线的分享一下进度啊。

59 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164855, encodeId=a26b21648551f, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：激光;口腔 经验分享：2分三区的杂志，审稿时间快慢不等。我自己遇到的编辑太忙，整个审稿过程单editor assignment pending就等了好几个月。如果见刊着急，这个杂志不是首选。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/3139c474f6e446a89f99c689b5b972c3/ef7907b6b2da40c78b0f038f424e69cd.png, createdBy=d8b52097943, createdName=lifesaver_80639729, createdTime=Wed Oct 25 17:12:57 CST 2023, time=2023-10-25, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2123944, encodeId=a2a7212394426, content=偏重的研究方向：医学;手术 经验分享：Reviewers agreed是说明已经有审稿人接受了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a55f8299328, createdName=宝强, createdTime=Wed Apr 05 20:46:35 CST 2023, time=2023-04-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=955270, encodeId=68009552e042, content=投稿命中率:50.0 经验分享：2020年9月2号投稿 2020年12月10小修 2021年1月1号修回 2021年2月10号接收目前还没有proof 速度偏慢。有没有已经在线的分享一下进度啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Thu Apr 08 18:33:35 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101717, encodeId=d99d2101e17b5, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：激光;疤痕 经验分享：Initial Date Submitted 12 Sep 2022 Accept 20 Nov 2022 速度还好，一次大修，一次小修，分值不高但是中科院3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33f36539713, createdName=ms9000000605363612, createdTime=Mon Nov 21 09:31:29 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093336, encodeId=a6852093336e5, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：医学;激光 经验分享：耐得住，真的好慢好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=692b6388930, createdName=ms3000001418780631, createdTime=Wed Oct 12 10:02:42 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555829, encodeId=096f5558294f, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：Dec 22, 2017 Submitted Dec 26, 2017 返回（缺动物伦理） Dec 27, 2017 Submitted Dec 27, 2017 Editor Invited Dec 28, 2017 Under Review Mar 25, 2018 Status Date变化（状态仍然为Under review） Mar 31, 2018 Minor Revise Apr 08, 2018 Submitted Apr 18, 2018 Under Review May 2, 2018 Reviews Completed May 3, 2018 Editor Assignment Pending May 4, 2018 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/8ab47519872135abb0a73648d5c28db5/e26e9c24b8c138494e359b288b9601d9.jpg, createdBy=96e82024468, createdName=欢乐的树博士, createdTime=Tue May 08 09:37:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011142, encodeId=3680101114230, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：激光;Supramaximal-area scars;大面积瘢痕 经验分享：18 Jun 2021 submitted 17 July 2021 under review 02 Aug 2021 minor 04 Aug 2021 revised + Editor invited 16 Aug 2021 Editor Assignemnt Pending 18 Aug 2021 ACCEPT Study focus on fractional CO2 laser treating Supramaximal-area scars, a retrospective study. Two months accept, I believe is worst a try. ^^, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1545312076, createdName=1488cc95m79(暂无昵称), createdTime=Tue Aug 24 21:57:59 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094654, encodeId=d7b8109465443, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094653, encodeId=75ef10946536f, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902348, encodeId=a9c190234813, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿后一个月编辑送审，外审两个月后大修，修回后又外审一个月，返回小修，小修后又送外审一月后接受。编辑态度比较严谨，对稿件格式要求很高，联系投稿前多检查几次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=301d2439800, createdName=zphgccf, createdTime=Thu Nov 26 02:04:05 CST 2020, time=2020-11-26, status=1, ipAttribution=)]

2022-11-21 ms9000000605363612

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：激光;疤痕
经验分享：Initial Date Submitted 12 Sep 2022
Accept 20 Nov 2022
速度还好，一次大修，一次小修，分值不高但是中科院3区

40 0

[GetPortalCommentsPageByObjectIdResponse(id=2164855, encodeId=a26b21648551f, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：激光;口腔 经验分享：2分三区的杂志，审稿时间快慢不等。我自己遇到的编辑太忙，整个审稿过程单editor assignment pending就等了好几个月。如果见刊着急，这个杂志不是首选。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/3139c474f6e446a89f99c689b5b972c3/ef7907b6b2da40c78b0f038f424e69cd.png, createdBy=d8b52097943, createdName=lifesaver_80639729, createdTime=Wed Oct 25 17:12:57 CST 2023, time=2023-10-25, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2123944, encodeId=a2a7212394426, content=偏重的研究方向：医学;手术 经验分享：Reviewers agreed是说明已经有审稿人接受了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a55f8299328, createdName=宝强, createdTime=Wed Apr 05 20:46:35 CST 2023, time=2023-04-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=955270, encodeId=68009552e042, content=投稿命中率:50.0 经验分享：2020年9月2号投稿 2020年12月10小修 2021年1月1号修回 2021年2月10号接收目前还没有proof 速度偏慢。有没有已经在线的分享一下进度啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Thu Apr 08 18:33:35 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101717, encodeId=d99d2101e17b5, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：激光;疤痕 经验分享：Initial Date Submitted 12 Sep 2022 Accept 20 Nov 2022 速度还好，一次大修，一次小修，分值不高但是中科院3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33f36539713, createdName=ms9000000605363612, createdTime=Mon Nov 21 09:31:29 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093336, encodeId=a6852093336e5, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：医学;激光 经验分享：耐得住，真的好慢好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=692b6388930, createdName=ms3000001418780631, createdTime=Wed Oct 12 10:02:42 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555829, encodeId=096f5558294f, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：Dec 22, 2017 Submitted Dec 26, 2017 返回（缺动物伦理） Dec 27, 2017 Submitted Dec 27, 2017 Editor Invited Dec 28, 2017 Under Review Mar 25, 2018 Status Date变化（状态仍然为Under review） Mar 31, 2018 Minor Revise Apr 08, 2018 Submitted Apr 18, 2018 Under Review May 2, 2018 Reviews Completed May 3, 2018 Editor Assignment Pending May 4, 2018 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/8ab47519872135abb0a73648d5c28db5/e26e9c24b8c138494e359b288b9601d9.jpg, createdBy=96e82024468, createdName=欢乐的树博士, createdTime=Tue May 08 09:37:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011142, encodeId=3680101114230, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：激光;Supramaximal-area scars;大面积瘢痕 经验分享：18 Jun 2021 submitted 17 July 2021 under review 02 Aug 2021 minor 04 Aug 2021 revised + Editor invited 16 Aug 2021 Editor Assignemnt Pending 18 Aug 2021 ACCEPT Study focus on fractional CO2 laser treating Supramaximal-area scars, a retrospective study. Two months accept, I believe is worst a try. ^^, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1545312076, createdName=1488cc95m79(暂无昵称), createdTime=Tue Aug 24 21:57:59 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094654, encodeId=d7b8109465443, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094653, encodeId=75ef10946536f, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902348, encodeId=a9c190234813, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿后一个月编辑送审，外审两个月后大修，修回后又外审一个月，返回小修，小修后又送外审一月后接受。编辑态度比较严谨，对稿件格式要求很高，联系投稿前多检查几次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=301d2439800, createdName=zphgccf, createdTime=Thu Nov 26 02:04:05 CST 2020, time=2020-11-26, status=1, ipAttribution=)]

2022-10-12 ms3000001418780631

审稿速度:12.0 | 投稿命中率:75.0
偏重的研究方向：医学;激光
经验分享：耐得住，真的好慢好慢啊

46 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164855, encodeId=a26b21648551f, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：激光;口腔 经验分享：2分三区的杂志，审稿时间快慢不等。我自己遇到的编辑太忙，整个审稿过程单editor assignment pending就等了好几个月。如果见刊着急，这个杂志不是首选。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/3139c474f6e446a89f99c689b5b972c3/ef7907b6b2da40c78b0f038f424e69cd.png, createdBy=d8b52097943, createdName=lifesaver_80639729, createdTime=Wed Oct 25 17:12:57 CST 2023, time=2023-10-25, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2123944, encodeId=a2a7212394426, content=偏重的研究方向：医学;手术 经验分享：Reviewers agreed是说明已经有审稿人接受了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a55f8299328, createdName=宝强, createdTime=Wed Apr 05 20:46:35 CST 2023, time=2023-04-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=955270, encodeId=68009552e042, content=投稿命中率:50.0 经验分享：2020年9月2号投稿 2020年12月10小修 2021年1月1号修回 2021年2月10号接收目前还没有proof 速度偏慢。有没有已经在线的分享一下进度啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Thu Apr 08 18:33:35 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101717, encodeId=d99d2101e17b5, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：激光;疤痕 经验分享：Initial Date Submitted 12 Sep 2022 Accept 20 Nov 2022 速度还好，一次大修，一次小修，分值不高但是中科院3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33f36539713, createdName=ms9000000605363612, createdTime=Mon Nov 21 09:31:29 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093336, encodeId=a6852093336e5, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：医学;激光 经验分享：耐得住，真的好慢好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=692b6388930, createdName=ms3000001418780631, createdTime=Wed Oct 12 10:02:42 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555829, encodeId=096f5558294f, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：Dec 22, 2017 Submitted Dec 26, 2017 返回（缺动物伦理） Dec 27, 2017 Submitted Dec 27, 2017 Editor Invited Dec 28, 2017 Under Review Mar 25, 2018 Status Date变化（状态仍然为Under review） Mar 31, 2018 Minor Revise Apr 08, 2018 Submitted Apr 18, 2018 Under Review May 2, 2018 Reviews Completed May 3, 2018 Editor Assignment Pending May 4, 2018 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/8ab47519872135abb0a73648d5c28db5/e26e9c24b8c138494e359b288b9601d9.jpg, createdBy=96e82024468, createdName=欢乐的树博士, createdTime=Tue May 08 09:37:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011142, encodeId=3680101114230, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：激光;Supramaximal-area scars;大面积瘢痕 经验分享：18 Jun 2021 submitted 17 July 2021 under review 02 Aug 2021 minor 04 Aug 2021 revised + Editor invited 16 Aug 2021 Editor Assignemnt Pending 18 Aug 2021 ACCEPT Study focus on fractional CO2 laser treating Supramaximal-area scars, a retrospective study. Two months accept, I believe is worst a try. ^^, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1545312076, createdName=1488cc95m79(暂无昵称), createdTime=Tue Aug 24 21:57:59 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094654, encodeId=d7b8109465443, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094653, encodeId=75ef10946536f, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902348, encodeId=a9c190234813, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿后一个月编辑送审，外审两个月后大修，修回后又外审一个月，返回小修，小修后又送外审一月后接受。编辑态度比较严谨，对稿件格式要求很高，联系投稿前多检查几次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=301d2439800, createdName=zphgccf, createdTime=Thu Nov 26 02:04:05 CST 2020, time=2020-11-26, status=1, ipAttribution=)]

2018-05-08 欢乐的树博士

审稿速度:3.0 | 投稿命中率:75.0
经验分享：Dec 22, 2017 Submitted
Dec 26, 2017 返回（缺动物伦理）
Dec 27, 2017 Submitted
Dec 27, 2017 Editor Invited
Dec 28, 2017 Under Review
Mar 25, 2018 Status Date变化（状态仍然为Under review）
Mar 31, 2018 Minor Revise
Apr 08, 2018 Submitted
Apr 18, 2018 Under Review
May 2, 2018 Reviews Completed
May 3, 2018 Editor Assignment Pending
May 4, 2018 Accept

298 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164855, encodeId=a26b21648551f, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：激光;口腔 经验分享：2分三区的杂志，审稿时间快慢不等。我自己遇到的编辑太忙，整个审稿过程单editor assignment pending就等了好几个月。如果见刊着急，这个杂志不是首选。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/3139c474f6e446a89f99c689b5b972c3/ef7907b6b2da40c78b0f038f424e69cd.png, createdBy=d8b52097943, createdName=lifesaver_80639729, createdTime=Wed Oct 25 17:12:57 CST 2023, time=2023-10-25, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2123944, encodeId=a2a7212394426, content=偏重的研究方向：医学;手术 经验分享：Reviewers agreed是说明已经有审稿人接受了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a55f8299328, createdName=宝强, createdTime=Wed Apr 05 20:46:35 CST 2023, time=2023-04-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=955270, encodeId=68009552e042, content=投稿命中率:50.0 经验分享：2020年9月2号投稿 2020年12月10小修 2021年1月1号修回 2021年2月10号接收目前还没有proof 速度偏慢。有没有已经在线的分享一下进度啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Thu Apr 08 18:33:35 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101717, encodeId=d99d2101e17b5, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：激光;疤痕 经验分享：Initial Date Submitted 12 Sep 2022 Accept 20 Nov 2022 速度还好，一次大修，一次小修，分值不高但是中科院3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33f36539713, createdName=ms9000000605363612, createdTime=Mon Nov 21 09:31:29 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093336, encodeId=a6852093336e5, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：医学;激光 经验分享：耐得住，真的好慢好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=692b6388930, createdName=ms3000001418780631, createdTime=Wed Oct 12 10:02:42 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555829, encodeId=096f5558294f, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：Dec 22, 2017 Submitted Dec 26, 2017 返回（缺动物伦理） Dec 27, 2017 Submitted Dec 27, 2017 Editor Invited Dec 28, 2017 Under Review Mar 25, 2018 Status Date变化（状态仍然为Under review） Mar 31, 2018 Minor Revise Apr 08, 2018 Submitted Apr 18, 2018 Under Review May 2, 2018 Reviews Completed May 3, 2018 Editor Assignment Pending May 4, 2018 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/8ab47519872135abb0a73648d5c28db5/e26e9c24b8c138494e359b288b9601d9.jpg, createdBy=96e82024468, createdName=欢乐的树博士, createdTime=Tue May 08 09:37:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011142, encodeId=3680101114230, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：激光;Supramaximal-area scars;大面积瘢痕 经验分享：18 Jun 2021 submitted 17 July 2021 under review 02 Aug 2021 minor 04 Aug 2021 revised + Editor invited 16 Aug 2021 Editor Assignemnt Pending 18 Aug 2021 ACCEPT Study focus on fractional CO2 laser treating Supramaximal-area scars, a retrospective study. Two months accept, I believe is worst a try. ^^, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1545312076, createdName=1488cc95m79(暂无昵称), createdTime=Tue Aug 24 21:57:59 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094654, encodeId=d7b8109465443, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094653, encodeId=75ef10946536f, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902348, encodeId=a9c190234813, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿后一个月编辑送审，外审两个月后大修，修回后又外审一个月，返回小修，小修后又送外审一月后接受。编辑态度比较严谨，对稿件格式要求很高，联系投稿前多检查几次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=301d2439800, createdName=zphgccf, createdTime=Thu Nov 26 02:04:05 CST 2020, time=2020-11-26, status=1, ipAttribution=)]

2021-08-24 1488cc95m79(暂无昵称)

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：激光;Supramaximal-area scars;大面积瘢痕
经验分享：18 Jun 2021 submitted
17 July 2021 under review
02 Aug 2021 minor
04 Aug 2021 revised + Editor invited
16 Aug 2021 Editor Assignemnt Pending
18 Aug 2021 ACCEPT

Study focus on fractional CO2 laser treating Supramaximal-area scars, a retrospective study.
Two months accept, I believe is worst a try. ^^

1 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164855, encodeId=a26b21648551f, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：激光;口腔 经验分享：2分三区的杂志，审稿时间快慢不等。我自己遇到的编辑太忙，整个审稿过程单editor assignment pending就等了好几个月。如果见刊着急，这个杂志不是首选。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/3139c474f6e446a89f99c689b5b972c3/ef7907b6b2da40c78b0f038f424e69cd.png, createdBy=d8b52097943, createdName=lifesaver_80639729, createdTime=Wed Oct 25 17:12:57 CST 2023, time=2023-10-25, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2123944, encodeId=a2a7212394426, content=偏重的研究方向：医学;手术 经验分享：Reviewers agreed是说明已经有审稿人接受了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a55f8299328, createdName=宝强, createdTime=Wed Apr 05 20:46:35 CST 2023, time=2023-04-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=955270, encodeId=68009552e042, content=投稿命中率:50.0 经验分享：2020年9月2号投稿 2020年12月10小修 2021年1月1号修回 2021年2月10号接收目前还没有proof 速度偏慢。有没有已经在线的分享一下进度啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Thu Apr 08 18:33:35 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101717, encodeId=d99d2101e17b5, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：激光;疤痕 经验分享：Initial Date Submitted 12 Sep 2022 Accept 20 Nov 2022 速度还好，一次大修，一次小修，分值不高但是中科院3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33f36539713, createdName=ms9000000605363612, createdTime=Mon Nov 21 09:31:29 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093336, encodeId=a6852093336e5, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：医学;激光 经验分享：耐得住，真的好慢好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=692b6388930, createdName=ms3000001418780631, createdTime=Wed Oct 12 10:02:42 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555829, encodeId=096f5558294f, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：Dec 22, 2017 Submitted Dec 26, 2017 返回（缺动物伦理） Dec 27, 2017 Submitted Dec 27, 2017 Editor Invited Dec 28, 2017 Under Review Mar 25, 2018 Status Date变化（状态仍然为Under review） Mar 31, 2018 Minor Revise Apr 08, 2018 Submitted Apr 18, 2018 Under Review May 2, 2018 Reviews Completed May 3, 2018 Editor Assignment Pending May 4, 2018 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/8ab47519872135abb0a73648d5c28db5/e26e9c24b8c138494e359b288b9601d9.jpg, createdBy=96e82024468, createdName=欢乐的树博士, createdTime=Tue May 08 09:37:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011142, encodeId=3680101114230, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：激光;Supramaximal-area scars;大面积瘢痕 经验分享：18 Jun 2021 submitted 17 July 2021 under review 02 Aug 2021 minor 04 Aug 2021 revised + Editor invited 16 Aug 2021 Editor Assignemnt Pending 18 Aug 2021 ACCEPT Study focus on fractional CO2 laser treating Supramaximal-area scars, a retrospective study. Two months accept, I believe is worst a try. ^^, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1545312076, createdName=1488cc95m79(暂无昵称), createdTime=Tue Aug 24 21:57:59 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094654, encodeId=d7b8109465443, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094653, encodeId=75ef10946536f, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902348, encodeId=a9c190234813, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿后一个月编辑送审，外审两个月后大修，修回后又外审一个月，返回小修，小修后又送外审一月后接受。编辑态度比较严谨，对稿件格式要求很高，联系投稿前多检查几次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=301d2439800, createdName=zphgccf, createdTime=Thu Nov 26 02:04:05 CST 2020, time=2020-11-26, status=1, ipAttribution=)]

2021-12-29 小动量

什么是correspondingauthor/通讯作者？

47 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164855, encodeId=a26b21648551f, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：激光;口腔 经验分享：2分三区的杂志，审稿时间快慢不等。我自己遇到的编辑太忙，整个审稿过程单editor assignment pending就等了好几个月。如果见刊着急，这个杂志不是首选。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/3139c474f6e446a89f99c689b5b972c3/ef7907b6b2da40c78b0f038f424e69cd.png, createdBy=d8b52097943, createdName=lifesaver_80639729, createdTime=Wed Oct 25 17:12:57 CST 2023, time=2023-10-25, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2123944, encodeId=a2a7212394426, content=偏重的研究方向：医学;手术 经验分享：Reviewers agreed是说明已经有审稿人接受了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a55f8299328, createdName=宝强, createdTime=Wed Apr 05 20:46:35 CST 2023, time=2023-04-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=955270, encodeId=68009552e042, content=投稿命中率:50.0 经验分享：2020年9月2号投稿 2020年12月10小修 2021年1月1号修回 2021年2月10号接收目前还没有proof 速度偏慢。有没有已经在线的分享一下进度啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Thu Apr 08 18:33:35 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101717, encodeId=d99d2101e17b5, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：激光;疤痕 经验分享：Initial Date Submitted 12 Sep 2022 Accept 20 Nov 2022 速度还好，一次大修，一次小修，分值不高但是中科院3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33f36539713, createdName=ms9000000605363612, createdTime=Mon Nov 21 09:31:29 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093336, encodeId=a6852093336e5, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：医学;激光 经验分享：耐得住，真的好慢好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=692b6388930, createdName=ms3000001418780631, createdTime=Wed Oct 12 10:02:42 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555829, encodeId=096f5558294f, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：Dec 22, 2017 Submitted Dec 26, 2017 返回（缺动物伦理） Dec 27, 2017 Submitted Dec 27, 2017 Editor Invited Dec 28, 2017 Under Review Mar 25, 2018 Status Date变化（状态仍然为Under review） Mar 31, 2018 Minor Revise Apr 08, 2018 Submitted Apr 18, 2018 Under Review May 2, 2018 Reviews Completed May 3, 2018 Editor Assignment Pending May 4, 2018 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/8ab47519872135abb0a73648d5c28db5/e26e9c24b8c138494e359b288b9601d9.jpg, createdBy=96e82024468, createdName=欢乐的树博士, createdTime=Tue May 08 09:37:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011142, encodeId=3680101114230, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：激光;Supramaximal-area scars;大面积瘢痕 经验分享：18 Jun 2021 submitted 17 July 2021 under review 02 Aug 2021 minor 04 Aug 2021 revised + Editor invited 16 Aug 2021 Editor Assignemnt Pending 18 Aug 2021 ACCEPT Study focus on fractional CO2 laser treating Supramaximal-area scars, a retrospective study. Two months accept, I believe is worst a try. ^^, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1545312076, createdName=1488cc95m79(暂无昵称), createdTime=Tue Aug 24 21:57:59 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094654, encodeId=d7b8109465443, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094653, encodeId=75ef10946536f, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902348, encodeId=a9c190234813, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿后一个月编辑送审，外审两个月后大修，修回后又外审一个月，返回小修，小修后又送外审一月后接受。编辑态度比较严谨，对稿件格式要求很高，联系投稿前多检查几次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=301d2439800, createdName=zphgccf, createdTime=Thu Nov 26 02:04:05 CST 2020, time=2020-11-26, status=1, ipAttribution=)]

2021-12-27 Mia

推荐同行评议时需要注意哪些情况？

45 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164855, encodeId=a26b21648551f, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：激光;口腔 经验分享：2分三区的杂志，审稿时间快慢不等。我自己遇到的编辑太忙，整个审稿过程单editor assignment pending就等了好几个月。如果见刊着急，这个杂志不是首选。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/3139c474f6e446a89f99c689b5b972c3/ef7907b6b2da40c78b0f038f424e69cd.png, createdBy=d8b52097943, createdName=lifesaver_80639729, createdTime=Wed Oct 25 17:12:57 CST 2023, time=2023-10-25, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2123944, encodeId=a2a7212394426, content=偏重的研究方向：医学;手术 经验分享：Reviewers agreed是说明已经有审稿人接受了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a55f8299328, createdName=宝强, createdTime=Wed Apr 05 20:46:35 CST 2023, time=2023-04-05, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=955270, encodeId=68009552e042, content=投稿命中率:50.0 经验分享：2020年9月2号投稿 2020年12月10小修 2021年1月1号修回 2021年2月10号接收目前还没有proof 速度偏慢。有没有已经在线的分享一下进度啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0f72309028, createdName=122220a4m01暂无昵称, createdTime=Thu Apr 08 18:33:35 CST 2021, time=2021-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101717, encodeId=d99d2101e17b5, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：激光;疤痕 经验分享：Initial Date Submitted 12 Sep 2022 Accept 20 Nov 2022 速度还好，一次大修，一次小修，分值不高但是中科院3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33f36539713, createdName=ms9000000605363612, createdTime=Mon Nov 21 09:31:29 CST 2022, time=2022-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093336, encodeId=a6852093336e5, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：医学;激光 经验分享：耐得住，真的好慢好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=692b6388930, createdName=ms3000001418780631, createdTime=Wed Oct 12 10:02:42 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555829, encodeId=096f5558294f, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：Dec 22, 2017 Submitted Dec 26, 2017 返回（缺动物伦理） Dec 27, 2017 Submitted Dec 27, 2017 Editor Invited Dec 28, 2017 Under Review Mar 25, 2018 Status Date变化（状态仍然为Under review） Mar 31, 2018 Minor Revise Apr 08, 2018 Submitted Apr 18, 2018 Under Review May 2, 2018 Reviews Completed May 3, 2018 Editor Assignment Pending May 4, 2018 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/8ab47519872135abb0a73648d5c28db5/e26e9c24b8c138494e359b288b9601d9.jpg, createdBy=96e82024468, createdName=欢乐的树博士, createdTime=Tue May 08 09:37:00 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011142, encodeId=3680101114230, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：激光;Supramaximal-area scars;大面积瘢痕 经验分享：18 Jun 2021 submitted 17 July 2021 under review 02 Aug 2021 minor 04 Aug 2021 revised + Editor invited 16 Aug 2021 Editor Assignemnt Pending 18 Aug 2021 ACCEPT Study focus on fractional CO2 laser treating Supramaximal-area scars, a retrospective study. Two months accept, I believe is worst a try. ^^, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1545312076, createdName=1488cc95m79(暂无昵称), createdTime=Tue Aug 24 21:57:59 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094654, encodeId=d7b8109465443, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094653, encodeId=75ef10946536f, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902348, encodeId=a9c190234813, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿后一个月编辑送审，外审两个月后大修，修回后又外审一个月，返回小修，小修后又送外审一月后接受。编辑态度比较严谨，对稿件格式要求很高，联系投稿前多检查几次。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=301d2439800, createdName=zphgccf, createdTime=Thu Nov 26 02:04:05 CST 2020, time=2020-11-26, status=1, ipAttribution=)]

2020-11-26 zphgccf

审稿速度:2.0 | 投稿命中率:50.0
经验分享：投稿后一个月编辑送审，外审两个月后大修，修回后又外审一个月，返回小修，小修后又送外审一月后接受。编辑态度比较严谨，对稿件格式要求很高，联系投稿前多检查几次。

135 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务